Patents by Inventor Jasper Rupert Clube

Jasper Rupert Clube has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PRECISION MEDICINE FOR CHOLESTEROL TREATMENT
    Publication number: 20240052025
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Application
    Filed: November 30, 2022
    Publication date: February 15, 2024
    Inventor: Jasper Rupert Clube
  • HUMAN TARGETS
    Publication number: 20230109430
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Application
    Filed: July 28, 2022
    Publication date: April 6, 2023
    Inventor: Jasper Rupert Clube
  • METHODS OF TREATING ANAEMIA
    Publication number: 20230024543
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Application
    Filed: July 8, 2021
    Publication date: January 26, 2023
    Inventor: Jasper Rupert Clube
  • Precision medicine for cholesterol treatment
    Patent number: 11555066
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: January 16, 2018
    Date of Patent: January 17, 2023
    Assignee: KYMAB LIMITED
    Inventor: Jasper Rupert Clube
  • Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment
    Patent number: 11434305
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: September 6, 2022
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Methods for treating neurodegenerative diseases using anti-PD-L1 antibodies
    Patent number: 10711059
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: July 14, 2020
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Targeting rare human PCSK9 variants for cholesterol treatment
    Patent number: 10618971
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: September 29, 2014
    Date of Patent: April 14, 2020
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Methods for treating neurodegenerative disease using anti-PD-1 antibodies
    Patent number: 10618955
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: April 14, 2020
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • HUMAN TARGETS
    Publication number: 20200109216
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Application
    Filed: November 21, 2019
    Publication date: April 9, 2020
    Applicant: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment
    Patent number: 10611849
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: November 25, 2014
    Date of Patent: April 7, 2020
    Assignee: KYMAB LIMITED
    Inventor: Jasper Rupert Clube
  • ANTI-PD-1 ANTIBODIES FOR CNS DISEASES
    Publication number: 20180222977
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Application
    Filed: March 29, 2018
    Publication date: August 9, 2018
    Applicant: Kymab Limited
    Inventor: Jasper Rupert Clube
  • ANTI-PD-L1 ANTIBODIES FOR CNS DISEASES
    Publication number: 20180215820
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Application
    Filed: March 29, 2018
    Publication date: August 2, 2018
    Applicant: Kymab Limited
    Inventor: Jasper Rupert Clube
  • PRECISION MEDICINE FOR CHOLESTEROL TREATMENT
    Publication number: 20180162935
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Application
    Filed: January 16, 2018
    Publication date: June 14, 2018
    Applicant: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Precision medicine for cholesterol treatment
    Patent number: 9914769
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: July 15, 2014
    Date of Patent: March 13, 2018
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • METHODS OF TREATING ANAEMIA
    Publication number: 20160319017
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Application
    Filed: July 15, 2016
    Publication date: November 3, 2016
    Applicant: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Methods of treating anaemia
    Patent number: 9439963
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: February 11, 2016
    Date of Patent: September 13, 2016
    Assignee: KYMAB LIMITED
    Inventor: Jasper Rupert Clube
  • Methods of treating anaemia
    Patent number: 9428578
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: February 11, 2016
    Date of Patent: August 30, 2016
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Precision medicine by targeting VEGF-A variants for treatment of diabetic macular edema and branch retinal vein occlusion
    Patent number: 9416180
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: April 26, 2016
    Date of Patent: August 16, 2016
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube
  • PRECISION MEDICINE BY TARGETING VEGF-A VARIANTS FOR TREATMENT OF DIABETIC MACULAR EDEMA AND BRANCH RETINAL VEIN OCCLUSION
    Publication number: 20160229907
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Application
    Filed: April 26, 2016
    Publication date: August 11, 2016
    Applicant: Kymab Limited
    Inventor: Jasper Rupert Clube
  • Methods of treating anaemia
    Patent number: 9394568
    Abstract: The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
    Type: Grant
    Filed: December 22, 2015
    Date of Patent: July 19, 2016
    Assignee: Kymab Limited
    Inventor: Jasper Rupert Clube